Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
Los costes cada vez mayores asociados con el desarrollo de fármacos constituyen una motivación importante a favor del uso de técnicas de medicina traslacional para mejorar la estratificación de los pacientes. Como tal, la necesidad de identificar biomarcadores para mejorar los modelos de estratificación de pacientes es cada vez más necesaria.
Your login attempt was not successful. Please try again.
Setup is fast and easy. Click below to register.
To view the complete webinar, choose from the available formats below, and simply click on the corresponding link. You must have the appropriate player to play the file. For more info on video players, please click here.